American Liver Foundation's $1.1 Million Initiative to Advance Liver Disease Research
American Liver Foundation's $1.1 Million Initiative to Advance Liver Disease Research
The American Liver Foundation (ALF) has proudly announced the recipients of its 2025 research awards, marking a significant milestone with a total funding amount of $1.1 million designated for liver disease research. This historic funding aims to support early-stage scientists, post-doctoral trainees, and junior faculty engaged in pioneering projects related to liver health and disease.
ALF's concerted effort to fund innovative studies reflects its commitment to tackling the pressing challenges posed by liver diseases, which affect approximately 100 million Americans. The research awards encompass various categories, including the Pilot Awards, Liver Scholar Awards, Postdoctoral Awards, and Travel Awards, all designed to foster groundbreaking research that could lead to advancements in treatment options and patient care.
A Closer Look at the Research Initiatives
Among the award recipients, nine innovative projects will benefit from the Pilot Awards, each receiving $50,000 for one year. These projects focus on rare yet critical liver diseases such as Primary Sclerosing Cholangitis (PSC), Primary Biliary Cholangitis (PBC), Autoimmune Hepatitis (AIH), Alpha-1 Antitrypsin Deficiency (AAID), and Hepatic Adenomas (HA). The objective is to nurture projects that explore new scientific territories or propose high-risk, high-reward hypotheses, potentially leading to breakthrough insights.
Dr. Emmanuel Thomas, the ALF Board Chair, emphasized the importance of this funding by stating, "ALF is so proud to fund $1.1 million in support of research projects that could help develop new and emerging drugs and treatment options addressing the needs of those living with liver disease."
In addition, Liver Scholar Awards will be granted to five junior faculty members selected in 2023 and 2024, providing them with $225,000 over three years (or $75,000 per year) to facilitate their research endeavors. This initiative aims to bolster the development of early-career scientists dedicated to exploring liver biology and diseases.
Lorraine Stiehl, CEO of ALF, commented, "Research is essential in improving, treating, and finding a cure for the 100 different types of liver diseases affecting millions of Americans today. It’s vital to provide early-career scientists the funding needed to conduct research that could lead to extraordinary medical breakthroughs."
Supporting Scientists in Their Journey
To further support the research community, ALF also offers Travel Awards that reimburse up to $1,500 for attending significant scientific conferences. Ten postdoctoral trainees demonstrating keen interest in liver research will benefit from these funds, enabling them to present their findings and network with other professionals in the field.
Moreover, the Postdoctoral Research Fellowship Award aims to provide an additional $25,000 stipend for one year to ten promising early-career scientists. This support is essential as they transition to independent research roles, reinforcing the pipeline of future researchers in liver disease.
Helene Jordan, PhD, National Senior Director of Research Program Management at ALF, expressed her enthusiasm: "Each year, we discover brilliant young minds working on research projects that tackle critical questions within the realm of basic and clinical research. These scientists represent the future of liver research, and their innovative projects hold tremendous potential to enhance our understanding of liver biology and disease."
Since its inception in 1980, ALF has dedicated nearly $30.1 million in research awards to over 920 researchers. This investment has not only contributed to significant advancements in liver-related science but has also inspired countless qualified professionals to pursue careers dedicated to the study of liver health.
For those interested in learning more about ALF's research program, visit liverfoundation.org/research for comprehensive information and updates.
The American Liver Foundation continues to stand as a beacon for the millions impacted by liver disease, advocating for patients, funding critical research, and fostering community engagement through various educational programs and resources.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.